PortfoliosLab logoPortfoliosLab logo
MDWD vs. AMGN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MDWD vs. AMGN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MediWound Ltd. (MDWD) and Amgen Inc. (AMGN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MDWD achieves a -25.62% return, which is significantly lower than AMGN's 4.83% return. Over the past 10 years, MDWD has underperformed AMGN with an annualized return of -13.00%, while AMGN has yielded a comparatively higher 11.09% annualized return.


MDWD

1D
-0.22%
1M
-20.45%
YTD
-25.62%
6M
-22.47%
1Y
-36.41%
3Y*
15.50%
5Y*
-10.58%
10Y*
-13.00%

AMGN

1D
3.03%
1M
5.23%
YTD
4.83%
6M
-0.66%
1Y
20.31%
3Y*
19.36%
5Y*
10.82%
10Y*
11.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MDWD vs. AMGN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MDWD
MediWound Ltd.
-25.62%3.71%75.02%-24.61%-18.34%-36.22%19.35%-23.65%-8.76%-2.82%
AMGN
Amgen Inc.
4.83%29.67%-6.77%13.46%20.43%0.87%-1.99%27.60%15.23%22.27%

Correlation

The correlation between MDWD and AMGN is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (10Y)
Calculated over the trailing 10-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Mar 21, 2014

0.14

Fundamentals

Market Cap

MDWD:

$176.76M

AMGN:

$183.99B

EPS

MDWD:

-$2.20

AMGN:

$14.38

PS Ratio

MDWD:

11.27

AMGN:

4.93

PB Ratio

MDWD:

4.27

AMGN:

20.02

Total Revenue (TTM)

MDWD:

$14.48M

AMGN:

$37.24B

Gross Profit (TTM)

MDWD:

$2.84M

AMGN:

$26.61B

EBITDA (TTM)

MDWD:

-$24.21M

AMGN:

$17.27B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MDWD vs. AMGN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDWD
MDWD Risk / Return Rank: 66
Overall Rank
MDWD Sharpe Ratio Rank: 77
Sharpe Ratio Rank
MDWD Sortino Ratio Rank: 99
Sortino Ratio Rank
MDWD Omega Ratio Rank: 1010
Omega Ratio Rank
MDWD Calmar Ratio Rank: 11
Calmar Ratio Rank
MDWD Martin Ratio Rank: 11
Martin Ratio Rank

AMGN
AMGN Risk / Return Rank: 6262
Overall Rank
AMGN Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
AMGN Sortino Ratio Rank: 6060
Sortino Ratio Rank
AMGN Omega Ratio Rank: 5858
Omega Ratio Rank
AMGN Calmar Ratio Rank: 6565
Calmar Ratio Rank
AMGN Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDWD vs. AMGN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MediWound Ltd. (MDWD) and Amgen Inc. (AMGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MDWDAMGNDifference
Sharpe ratioReturn per unit of total volatility

-1.63

Sortino ratioReturn per unit of downside risk

-2.48

Omega ratioGain probability vs. loss probability

0.86

1.16

-0.30

Calmar ratioReturn relative to maximum drawdown

-0.99

1.23

-2.23

Martin ratioReturn relative to average drawdown

-1.98

2.91

-4.89

MDWD vs. AMGN - Sharpe Ratio Comparison

The current MDWD Sharpe Ratio is -0.88, which is lower than the AMGN Sharpe Ratio of 0.75. The chart below compares the historical Sharpe Ratios of MDWD and AMGN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MDWDAMGNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.88

0.75

-1.63

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.17

0.46

-0.63

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.21

0.45

-0.66

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.27

0.61

-0.88

Drawdowns

MDWD vs. AMGN - Drawdown Comparison

The maximum MDWD drawdown since its inception was -94.35%, which is greater than AMGN's maximum drawdown of -63.48%. Use the drawdown chart below to compare losses from any high point for MDWD and AMGN.


Loading charts...

Drawdown Indicators


MDWDAMGNDifference

Max Drawdown

Largest peak-to-trough decline

-94.35%

-63.48%

-30.87%

Max Drawdown (1Y)

Largest decline over 1 year

-36.73%

-16.57%

-20.16%

Max Drawdown (3Y)

Largest decline over 3 years

-38.26%

-22.74%

-15.52%

Max Drawdown (5Y)

Largest decline over 5 years

-82.04%

-24.86%

-57.18%

Max Drawdown (10Y)

Largest decline over 10 years

-87.76%

-24.86%

-62.90%

Current Drawdown

Current decline from peak

-89.20%

-12.21%

-76.99%

Average Drawdown

Average peak-to-trough decline

-75.87%

-16.78%

-59.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.42%

7.00%

+11.42%

Volatility

MDWD vs. AMGN - Volatility Comparison

MediWound Ltd. (MDWD) has a higher volatility of 16.88% compared to Amgen Inc. (AMGN) at 6.10%. This indicates that MDWD's price experiences larger fluctuations and is considered to be riskier than AMGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MDWDAMGNDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.88%

6.10%

+10.78%

Volatility (6M)

Calculated over the trailing 6-month period

30.96%

19.13%

+11.83%

Volatility (1Y)

Calculated over the trailing 1-year period

41.72%

27.24%

+14.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.09%

23.86%

+37.23%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.81%

24.81%

+36.00%

Dividends

MDWD vs. AMGN - Dividend Comparison

MDWD has not paid dividends to shareholders, while AMGN's dividend yield for the trailing twelve months is around 2.90%.


PositionTTM20252024202320222021202020192018201720162015
AMGN
Amgen Inc.
2.90%2.91%3.45%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%
MDWD
MediWound Ltd.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MDWD vs. AMGN - Financials Comparison

This section allows you to compare key financial metrics between MediWound Ltd. and Amgen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B20222023202420252026
1.48M
8.62B
(MDWD) Total Revenue
(AMGN) Total Revenue
Values in USD except per share items

Frequently Asked Questions


MDWD and AMGN have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MDWD has higher volatility (16.88%) compared to AMGN (6.10%). In terms of maximum drawdown, MDWD dropped -94.35% vs AMGN's -63.48%.

AMGN currently has the higher Sharpe Ratio (0.75 vs -0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MDWD and AMGN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer